| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |